The Association Between MTHFR C677T Polymorphism and Homocysteine Levels as Risk Factors for Coronary Artery Disease: A Case-Control study

Saeideh Amani; Ebrahim Mirzajani; Seyed Mehrdad Kassaee; Minoo Mahmoudi; Fardin Mirbolouk

doi:10.34172/cjmb.2023.3670

E-ISSN : 2148-9696

Crescent Journal of
Medical and Biological Sciences

Main Page Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jul 2024, Vol 11, Issue 3

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
The Association Between MTHFR C677T Polymorphism and Homocysteine Levels as Risk Factors for Coronary Artery Disease: A Case-Control study
Saeideh Amani¹, Ebrahim Mirzajani^2,3, Seyed Mehrdad Kassaee¹, Minoo Mahmoudi¹, Fardin Mirbolouk⁴
¹Department of Biology, Hamedan Branch, Islamic Azad University, Hamedan, Iran ²Department of Biochemistry, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran ³Cellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran ⁴Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
DOI: 10.34172/cjmb.2023.3670 Viewed : 424 times Downloaded : 647 times. Keywords : Coronary artery disease, Homocysteine, Methylenetetrahydrofolate reductase (MTHFR), MTHFR C677T polymorphism
Full Text(PDF) \| Related Articles
Abstract

Objectives: Coronary artery disease (CAD) is the leading cause of disability and global death. Homocysteine is a major risk factor for CAD. High plasma homocysteine levels are an independent risk factor for this disease. Methylenetetrahydrofolate reductase (MTHFR) is one of the essential enzymes of homocysteine metabolism. In this way, mutations of genes encoding enzyme reduce its activity, which can increase blood homocysteine levels and ultimately raise the risk of CAD. Accordingly, this study aimed to investigate the association between MTHFR C677T polymorphism and homocysteine with CAD disease. Materials and Methods: The present investigation is a case-control study conducted on the patients of Heshmat hospital, Rasht, Iran. The demographic characteristics of 90 patients and 76 controls were obtained by questionnaires and blood samples were collected to evaluate homocysteine levels and gene polymorphism. MTHFR C677T polymorphism and blood homocysteine levels were assessed using amplification refractory mutation system polymerase chain reaction (ARMS-PCR) and ELISA, respectively, and a comparison was made between the two groups. The statistical analysis of the data was performed using SPSS software, version 21. Results: The frequency of C677T polymorphism genotypes in the control and patient groups was not statistically significant (P = 0.384). The highest frequency of genotype in the control (46.1%) and patient (50%) groups was shown in CT. Plasma homocysteine levels were significantly higher in CAD patients than in the control group (P = 0.001). Conclusion: The results of this study showed that the TT genotype of C677T polymorphism has a protective effect on CAD. Although the results obtained for C677T polymorphism are not statistically significant, this genotype had little effect on atherosclerosis. Consequently, the interaction of MTHFR gene polymorphism with CAD may be due to C677T genotype and homocysteine levels in the selected population of Guilan.